Key Highlights
- Dual-peptide research blend
- High-purity lyophilized formulation
- Third-party tested by a reputable USA laboratory (COA available)
- Secure, sealed vial for stability
- Ships from USA
CJC-1295 + Ipamorelin – Research Peptide Blend
CJC-1295 and Ipamorelin are two research peptides commonly studied together for their interaction with growth hormone–related signaling pathways in controlled laboratory environments.
This combination is frequently used in research models to examine how different mechanisms of receptor interaction may influence growth hormone signaling, growth hormone levels, and downstream biological processes.
Why This Combination Stands Out
CJC-1295 and Ipamorelin interact with growth hormone signaling through complementary mechanisms:
-
CJC-1295 is a GHRH analog that targets growth hormone–releasing hormone pathways and supports natural growth hormone production
-
Ipamorelin is a selective ghrelin receptor (GHS-R) agonist studied for its role in stimulating GH-related signaling
This dual-mechanism approach allows researchers to study how multiple signaling pathways interact within the endocrine system.
Research Overview
In controlled laboratory settings, this combination is commonly examined for:
- Growth hormone signaling pathway interaction
- Multi-pathway receptor activation (GHRH + ghrelin pathways)
- Endocrine system response models
- Downstream metabolic and regulatory signaling
The combination allows for analysis of how different signaling inputs may influence overall pathway behavior in experimental models.
Research Focus Areas
Researchers frequently evaluate this combination in studies involving:
- Growth hormone signaling pathways
- Endocrine system regulation models
- Peptide interaction and signaling synergy
- Metabolic processes related to GH signaling
The use of two complementary peptides enables more complex experimental design compared to single-compound studies.
Product Specifications
-
Form: Lyophilized powder
-
Compounds: CJC-1295 + Ipamorelin
-
Blend Type: Dual-peptide formulation
-
Appearance: White/off-white powder
-
Purity: ≥98–99% (match your COA)
-
Stability: Long shelf-life under proper storage conditions
Storage & Handling
- Store in a cool, dry environment
- Refrigeration recommended for extended stability
- Avoid exposure to heat and direct light
Quality & Testing
Each batch undergoes strict quality control and third-party analytical testing to verify purity and consistency.
A Certificate of Analysis (COA) is available for full transparency and batch verification prior to research use.
Shipping & Processing
- Fast U.S.-based fulfillment
- Discreet, secure packaging
- Orders processed same day if ordered before 5PM EST, next day if ordered after 5PM EST
FAQ
What does the Certificate of Analysis for CJC-1295/Ipamorelin verify?
Each batch is tested by a third-party laboratory to confirm identity and purity of the CJC-1295 and Ipamorelin components. The Certificate of Analysis documents batch-specific results and is available for download before purchase.
How should CJC-1295/Ipamorelin be stored?
Store the lyophilized powder in a cool, dry environment away from heat and light. Refrigeration is recommended for extended stability.
What is the purity standard for this blend?
CJC-1295/Ipamorelin is manufactured to ≥99% purity, verified by third-party analytical testing and documented on the Certificate of Analysis.
How is batch identification handled?
Each vial corresponds to a specific lot/batch number tied to its own Certificate of Analysis, so researchers can verify testing results for the exact batch received.
